However, apart from the roles of PFN1 in cytoskeleton remodeling, it has been reported that PFN1 regulates drug resistance within the interaction of p53 in breast cancer cells and also exhibits the roles in autophagy-mediated drug resistance interacting with the Beclin1 complex in multiple myeloma [10]. This evidence concerns the gene PFN1 and breast carcinoma.